Cargando…
Immunotherapy in Glioblastoma: A Clinical Perspective
SIMPLE SUMMARY: Glioblastoma is the most frequent and the most aggressive brain tumor. Even with the most current treatment, its prognosis remains dismal. Immunotherapies, novel cancer therapies using the patient’s own immune system to fight cancer, have revolutionized the treatment of numerous canc...
Autores principales: | Desbaillets, Nicolas, Hottinger, Andreas Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345081/ https://www.ncbi.nlm.nih.gov/pubmed/34359621 http://dx.doi.org/10.3390/cancers13153721 |
Ejemplares similares
-
Standards of care and novel approaches in the management of glioblastoma multiforme
por: Hottinger, Andreas F., et al.
Publicado: (2014) -
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
por: Sener, Ugur, et al.
Publicado: (2022) -
IL-2 TUMOR TREATING FIELDS: IMPROVING THE ODDS FOR PATIENTS WITH GLIOBLASTOMA
por: Hottinger, Andreas F
Publicado: (2022) -
Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
por: Yang, Minfeng, et al.
Publicado: (2020) -
Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis
por: Desbaillets, Isabelle, et al.
Publicado: (1997)